期刊文献+

激光诱导小鼠脉络膜新生血管中补体C3的作用 被引量:2

Role of complement C3 in laser-induced choroidal neovascularization of rat
下载PDF
导出
摘要 目的探讨激光诱导脉络膜新生血管(choroidal neovasculature,CNV)形成机制中补体的作用。方法用氪红激光对小鼠行实验性视网膜激光光凝,建立CNV动物模型,共聚焦显微镜下观察CNV发生情况,检测补体溶血活性(CH50),用免疫组织化学方法检测补体C3,用RT-PCR分析C3a受体mRNA的表达。结果激光后第7天,对照组C57BL/6小鼠见CNV形成,而眼镜蛇毒因子(cobra venom factor,CVF)预处理组及C3-/-小鼠组未见CNV形成。CVF预处理组小鼠补体的CH50于激光后第1天、第3天、第5天、第7天分别为2%、3%、3%、2%,同时间点对照组均为100%,差异均有显著统计学意义(均为P<0.001)。激光后第1天,对照组RPE-脉络膜-巩膜复合体见C3强阳性染色,CVF预处理组及C3-/-小鼠组未见C3阳性染色。激光后对照组C57BL/6小鼠较激光前,C3a受体mRNA表达增强,激光后第5天,C3a受体mRNA水平达到高峰,并在激光后第7天维持较高水平,而CVF预处理组小鼠及缺乏补体C3的C3-/-小鼠组激光前后未见明显改变。结论氪激光诱导CNV模型,补体C3参与CNV形成。补体系统的存在和激活是激光诱导CNV形成的必要条件。 Objective To study the role of complement C3 in laser-induced choroidal neovascularization(CNV) of rat.Methods CNV model was established by experimental laser photocoagulation with the krypton red laser,the incidence of CNV was determined by confocal microscope,the hemolysis activity(CH50) of complement was detected,and the complement C3 was tested by immunohistochemical method,RT-PCR analysis was used to examine the expression of C3R mRNA.Results At 7 days after laser treatment,CNV was induced successfully in C57/BL6 mice of control group,but no CNV was found in CVF pre-treated group and C3-/-rat group.The CH50 of complement in CVF pre-treated group at 1 day,3 days,5 days,7 days after laser treatment were 2%,3%,3% and 2%,respectively,which in control group were all 100%,there were significant differences(all P0.001).At 1 day after laser treatment,the complement C3 was strong positive stained in RPE-choroid-scleral complex of control group,but negative stained in CVF pre-treated group and C3-/-rat group.In C57/BL6 mice of control group,C3R mRNA level after laser treatment higher than that before laser treatment,peaked at 5 days,and sustained the high level at 7 days after laser treatment,but there was no change in CVF pre-treated group and C3-/-rat group before and after laser treatment.Conclusion The complement C3 takes part in the CNV formation,the presence and the activation of complement system are essential for the development of laser-induced CNV in mice.
作者 许琴 肖煜晨
出处 《眼科新进展》 CAS 北大核心 2011年第8期734-736,共3页 Recent Advances in Ophthalmology
关键词 脉络膜新生血管 补体 补体C3 choroidal neovascularization complement complement C3
  • 相关文献

参考文献10

  • 1Tezel TH, Bora NS, Kaplan HJ. Pathogenesis of age-related macular degeneration[J].Trends Mol Med,2010, 10(9) :417-420.
  • 2Husain D,Ambati B ,Adamis AP, Miller JW. Mechanisms of agerelated macular degeneration [ J ]. Ophthalmol Clin North Am. 2002,15 ( 1 ) :87-91.
  • 3Farrar CA, Zhou W, Lin T, Sacks SH. Local extravascular pool of C3 is a determinant of postischemic acute renal failure [ J ]. FASEB J,2006,20(2) :217-226.
  • 4Sakurai E,Anand A,AmbatJ BK,van Rooijen N,Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization[J]. Invest Ophthalmol Vis Sci ,2003,44( 8 ) :3578-3585.
  • 5Campochiaro PA. Retinal and choroidal neovascularization [J].J Cell Physiol,2000,184 ( 3 ) :301-310.
  • 6Bora PS, Sohn JH, Cruz JM, Jha P, Nishihori H, Wang Y. et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization [ J ]. J Immunol, 2005,174( 1 ) :491-497.
  • 7Bora NS, Kaliappan S, Jha P, Xu Q, Sivasankar B, Harris CL. et al. CD59, a Complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degenerationl [ J ]. J Immunol, 2007, 178 ( 3 ) : 1783- 1790.
  • 8Sohn JH, Kaplan H J, Suk H J, Bora PS, Bora NS. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins investigative [ J ]. Invest Ophthalmol Vis Sci ,2000,41 (11 ) :3492-3502.
  • 9Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, et al. A second serine protease associated with mannan-binding lectin that, activates complement[J]. Nature, 1997, 385 (5624) :505-510.
  • 10Sohn JH, Bora PS, Suk H J, Molina H, Kaplan H J, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells [J]. Nat Med, 2003,9 ( 2 ) : 206-212.

同被引文献20

  • 1Tezel TH,Bora NS,Kaplan HJ. Pathogenesis of age-related mac-ular degeneration[ J]. Trends Mol Med,2004,10(9) :417-420.
  • 2Ferris FL 3rd,Fine SL,Hyman L. Age-related macular degenera-tion and blindness due to neovascular macvilopathy [ J]. ArchOphthalmol,1984,102(11) ; 1640-1642.
  • 3Klein RJ, Zeiss C, Chew EY, Tsai JY,Sackler RS, Haynes C,etai. Complement factor H polymorphism in age-related maculardegeneratlon[ J]. Science,2005 ,308(5720) :385-389.
  • 4Hageman GS,Anderson DH, Johnson LV,Hancox LS,Taiber AJ,Hardisty LI,ei al. A common haplotype in the complement regu-latory gene factor H(HF1/CFH) predisposes individuals to age-related macular degeneration [ J ]. Proc Natl Acad Sci USA,2005,102(20) :7227-7232.
  • 5Acosta J,Hettinga J,Fluckiger R,Krumrei N,Goldfine A,Angari-ta L,ei al. Molecular basis for a link between complement andthe vascular complications of diabetes [ J ]. Proc Natl Acad SciUSA,2000,91 (10) :5450-5455.
  • 6Morgan BP. Effects of the membrane attack complex of comple-ment of nucleated cells [ J ]. Curr Top Microbiol Immunol,1992,178(1) :115-140.
  • 7Bora NS,Kaliappan S,Jha P,Xu Q,Sivasankar B,Harris CL,etal. CD59,a complement regulatory protein controls choroidalneovascularization in a mouse model of wet-type age-relatedmacular degeneration[ J]. J Immunol,2007,178(3) :1783-1790.
  • 8Bora NS, Kaliappan S,Jha P,Xu Q,Sohn JH, Dhaulakhandi DB,et al. Complement activation via alternative pathway is criticalin the development of laser-induced choroidal neovasculariza-tion :role of factor B and factor H [ J]. J Immunol, 2006,177(3):1872-1878.
  • 9Kwak N,Okamoto N,Wood JM,Campochiaro PA. VEGF is ma-jor stimulator in model of choroidal neovascularization [ J ]. In-vest Ophthalmol Vis 5ci,2Q00,4l(l0) -.3158-3164.
  • 10Hera R, Keramidas M, Peocoh M, Mouillon M, Romanet JP,Feige JJ. Expression of VEGF and angiopoietins in subfovealmembranes from patients with age-related macular degenerationOphthalmol ,2005,139(4) :589-596.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部